Ashwin Kashyap, M.D.

805-496-2949
Ashwin Kashyap, M.D.
Medical Oncologist and Hematologist
Clinical Expertise
  • Hematology-Oncology
Academic Appointments
  • Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research
Clinical Teams
Medical Oncology & Therapeutics Research

Dr. Kashyap was everything I'd hope my doctor would be ... courteous, understanding, respectful and truly showing an interest in my health.

Patients rave about Ashwin Kashyap, M.D., praising his skills and especially his compassion, which he says he learned from his own role model; a physician who treated him as a child: “His kindness and attention made a huge difference to both myself and subsequently all of my family,” he said. “I was inspired by him to pay it forward and do the same for others.”

Raised in the U.K., Dr. Kashyap received his medical degree at University College London where he also completed his internship. He served residencies at Australia’s Williamstown Hospital and New York’s University of Rochester, where he also completed fellowships in medical oncology and hematology.

Dr. Kashyap is pleased to return to City of Hope where he served for several years as a key member of the hematology and bone marrow transplantation team. He brings with him several years of specialized private sector experience developing and testing new cancer treatments. “City of Hope's altruistic, humanistic, compassionate and research-oriented philosophy is unique in this world,” he said, “and very much in keeping with my own views on how health care should be run.”

Location

Education & Experience

Board Certifications

  • 2005, American Board of Internal Medicine, Hematology
  • 2004, American Board of Internal Medicine, Medical Oncology
  • 2001, American Board of Internal Medicine

Degrees

  • 1980–1985, Royal Free Hospital School of Medicine (now University College London), London University, London, England
  • 1977–1979, Harrow College of Higher Education (now Westminster University), London, England

Fellowship

  • 1992–1993, Hematology, Research, University of Rochester, Rochester, NY
  • 1991–1992, Medical Oncology, Clinical
  • 1990–1991, Hematology, Clinical

Residency

  • 1989–1990, Chief Resident, Internal Medicine, University of Rochester, Rochester, NY
  • 1988–1989, Resident, Internal Medicine, University of Rochester, Rochester, NY
  • 1986–1988, Family Medicine, Williamstown Hospital, Melbourne, Victoria, Australia

Internship

  • 1985–1986, Medicine and Surgery, University College London, London University, London, England

Professional Experience

  • 2020–present, Physician and Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Thousand Oaks, CA
  • 2015–2016, Chief of Medicine, Los Robles Hospital, Thousand Oaks, CA
  • 2005–2007, Chair, Simi Valley Hospital Cancer Committee, Simi Valley, CA
  • 1999–2001, Physician, Department of Informatics, City of Hope, Duarte, CA
  • 1994–2001, Physician, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
  • 1989–1990, Chief Resident Internal Medicine, University of Rochester, Rochester, NY

Awards & Memberships

Awards

  • 2000, Fellow, American College of Physicians
  • 1992, NIH Institutional Fellowship Research Award
  • 1985, Certificate of Merit in Pathology
  • 1982, Distinction in Biochemistry
  • 1981, Certificate of Merit in Biochemistry

Memberships

  • Fellow of the American College of Physicians
  • Member of the American Society of Hematology
  • Member of American Society for Clinical Oncology
  • Member of European Hematology Association
  • Member SWOG Bone Marrow and Stem Cell Transplant Committee
  • Member of the American Society for Blood and Marrow Transplantation

Publications

  • Snowden JA, Passweg J, Moore JJ, Milliken S, Cannell P, Van Laar J, Verburg R, Szer J, Taylor K, Joske D, Rule S, Bingham SJ, Emery P, Burt RK, Lowenthal RM, Durez P, McKendry RJ, Pavletic SZ, Espigado I, Jantunen E, Kashyap A, Rabusin M, Brooks P, Bredeson C, Tyndall A. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. Journal of Rheumatology. 2004 Mar;31(3):482-8.
  • Andersson BS, Kashyap A, Couriel D, Madden T, de Lima M, Thall PF, Fernandez H, Vaughan WP, Jones R, Wingard JR, Blume KG, Champlin RE. Intravenous busulfan in pretransplant chemotherapy: bioavailability and patient benefit. Biology of Blood and Marrow Transplantation. 2003 Nov; 9(11):722-4.
  • Kashyap A, Wingard J, Cagnoni P, Tarantolo S, Fernandez H, Hu W, Niland J, Vaughan WP, Jones RP, Blume K, Champlin R, Forman SJ, Andersson BS. Intravenous (IV) vs Oral Busulfan (BU) as Part of a Bu/Cy (Cyclosphosphamide) Preparative Regimen for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT). Decreased Incidence of Hepatic Veno-Occlusive Disease (VOD), VOD related Mortality and Overall 100-Day Mortality. Biology of Blood and Marrow Transplantation. 2002;8(9):493-500.
  • Fassas A, Passweg PR, Anagnostopoulos A, Kazis A, Kozak T, Carreras E, Kashyap A, Openshaw H, Schipperus M, Deconinck E, Mancardi G, Marmont A, Hansz J, Rabusin M, Nagore FJ, Besalduch J, Dentamaro T, Fouillard L, Hertenstein B, Marrosu M, Musso M, Papineschi F, Rowe J, Saccardi R, Gratwohl A, Tyndall A. Autoimmune Disease Working Party of the EBMT. Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Retrospective Multicenter Study. Journal of Neurology. 2002 Aug; 249(8):1088-97.
  • Andersson BS, Kashyap A, Gian V, Wingard J, Fernandez H, Cagnoni P, Jones R, Tarantolo S, Hu W, Blume K, Forman SJ, Champlin RE. Conditioning Therapy with Intravenous Busulfan and Cyclophosphamide (IV BuCy2) for Hematologic Malignancies Prior to Allogeneic Stem Cell Transplantation. A phase II study. Biology of Blood and Marrow Transplantation. 2002; 8(3):145-54.
  • Kashyap A, Snowden J. Considerations in the Selection of an Appropriate Conditioning Regimen for the Treatment of Rheumatoid Arthritis by Autologous Peripheral Blood Stem Cell Transplantation. The Journal of Rheumatology 2001; 28 Suppl 64:39-41.
  • Khoury H, Kashyap A, Adkins DR, Brown RA, Miller G, Vij R, Westervelt P, Trinkaus K, Goodnough LT, Hayashi RJ, Parker P, Forman SJ, DiPersio JF. Treatment of Steroid Resistant Acute Graft-Versus-Host Disease with Anti-Thymocyte Globulin. Bone Marrow Transplant 2001 May; 27(10):1059-64.
  • Binks M, Passweg JR, Furst D, McSweeney P, Sullivan K, Besenthal C, Finke J, Peter HH, van Laar J, Breedveld FC, Fibbe WE, Farge D, Gluckman E, Locatelli F, Martini A, van den Hoogen F, van de Putte L, Schattenberg AV, Arnold R, Bacon PA, Emery P, Espigado I, Hertenstein B, Hiepe F, Kashyap A, Kotter I, Marmont A, Martinez A, Pascual MJ, Gratwohl A, Prentice HG, Black C, Tyndall A. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis 2001 Jun;60(6):577-84.
  • Bhatia S, Louie A, Bhatia R, O’Donnell M, Fung H, Kashyap A, Krishnan A, Molina A, Nademanee A, Niland J, Parker P, Snyder D, Spielberger R, Stein A, Forman SJ. Solid Cancers Following Bone Marrow Transplant. J Clin Oncol 2001; 19: 464-471.
  • Bensinger W, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R, Kashyap A, Flowers MED, Lilleby K, Chauncey T, Storb R, Blume K, Heimfield S, Rowley S, Appelbaum F. Transplantation of Bone Marrow as Compared with Peripheral Blood Cells from HLA Identical Relatives in Patients with Hematologic Cancers. New England Journal of Medicine 2001, 344; 175-181.
  • Molina A, Popplewell L, Kashyap A, Nademanee A. Hematopoietic stem cell transplantation in the new millennium: report from City of Hope National Medical Center. Clin Transplant. 2000:317-42.
  • Openshaw H, Lund B, Kashyap A, Atkinson R, Sniecinski I, Weiner LP, Forman SJ. Peripheral Blood Stem Cell Transplant in Multiple Sclerosis with Busulfan and Cyclophosphamide Conditioning: Report of Toxicity and Immunological Monitoring. Biology of Blood and Marrow Transplantation 2000; 6:563-575.

Ratings & Reviews

Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with five stars being the highest.
5.0
Provider explain in way you understand
5.0
Provider listen carefully to you
5.0
Show respect for what you say
4.9
Recommend this provider office
4.9
Know important info medical history
4.9
Spend enough time with you
4.9
Rate provider 0-10
02/26/26
Kind, good listener, explains everything, including options calmly, making sure I understand it all and encouraging. I'll recommend him anytime! - Verified patient
02/25/26
My blood test results are sent to me to review quickly after the draw and although I do review them, the doctor always explains them. Luckily my last cancer surgery & treatments were in 2017 but it's always a concern and then comforting to hear you are doing well - great staff & physician - Verified patient
02/17/26
Kind doctor and staff - Verified patient
01/11/26
I would highly recommend the City of Hope to anyone that needs their services. Always made me comfortable and offered water, snacks, - Verified patient
11/13/25
Dr. Kashyap is excellent in all aspects. - Verified patient